Back to top
more

ALPS Medical Breakthroughs ETF: (SBIO)

(Delayed Data from NYSE) As of Apr 25, 2024 04:00 PM ET

$31.53 USD

31.53
19,606

-0.33 (-1.04%)

Volume: 19,606

Zacks ETF Rank

This is our ETF rating system that serves as a timeliness indicator for ETFs over the next 6 months:

Zacks Rank Definition
1 Strong Buy
2 Buy
3 Hold
4 Sell
5 Strong Sell

See all the Top Ranked ETFs here - The complete list of all the top ranked ETFs

3 - Hold of 5     3    

After-Market: $31.44 -0.09 (-0.29 %) 7:58 PM ET

ETF Quote Details

Previous Close 31.86
Open 31.30
Bid 30.87
Ask 32.15
Day Low-High 31.00-31.57
52wk Low-High 23.21-38.80
Volume 19,606
NAV (month end) 35.83
Premium (+)/Discount (-) (month end)-3.97

Zacks Premium Research for SBIO

Zacks ETF Rank

This is our ETF rating system that serves as a timeliness indicator for ETFs over the next 6 months:

Zacks Rank Definition
1 Strong Buy
2 Buy
3 Hold
4 Sell
5 Strong Sell

See all the Top Ranked ETFs here - The complete list of all the top ranked ETFs

 Hold 3
ETF Risk

Zacks proprietary quantitative models divide each set of ETFs following a similar investment strategy (style box/industry/asset class) into three risk categories- High, Medium, and Low. The aim of our models is to select the best ETFs within each risk category, so that investors can pick an ETF that matches their particular risk preference in order to better achieve their investment goals.

High
ETF Snapshot

ETF Expense Ratio

Expense Ratio 0.50%
Dividend (Yield) $0.07 (0.22%)
Issuer ALPS

Benchmark for SBIO

S-NETWORK MEDICAL BREAKTHROUGHS INDEX

The S-Network Medical Breakthroughs Index captures research & development opportunities in the pharmaceutical industry. It consists of small-cap and mid-cap pharmaceutical and biotechnology stocks listed on US stock exchanges that have one or more drugs in either Phase II or Phase III US FDA clinical trials.

Fund Summary for SBIO

ALPS MEDICAL BREAKTHROUGHS ETF

The ALPS Medical Breakthroughs ETF seeks investment results that correspond, before fees and expenses, to the performance of S-Network Medical Breakthroughs Index.